시장보고서
상품코드
1460734

세계의 바이오 촉매 시장 : 시장 규모 및 점유율 분석(원료별, 종류별, 용도별) - 산업 수요 예측(-2030년)

Biocatalyst Market Size and Share Analysis by Source, Type, Application - Global Industry Demand Forecast to 2030

발행일: | 리서치사: Prescient & Strategic Intelligence | 페이지 정보: 영문 240 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

시장 개요

세계 바이오 촉매 시장 규모는 2023년 6억 760만 달러로 2024년부터 2030년까지 연평균 6.3% 성장하여 2030년에는 9억 2,520만 달러에 달할 것으로 예측됩니다.

생물 유래 바이오 촉매는 각종 산업 분야에서 일반적으로 석유 유래 합성 촉매를 대체할 수 있는 친환경 촉매입니다. 특수 화학제품과 범용 화학제품 생산에 중요한 역할을 하고 있습니다.

생물촉매의 가장 두드러진 산업적 응용은 의약품의 향과 향료에 사용되는 입체특이적 화합물(키랄 화합물이라고도 함)입니다. 키랄성 수산기를 가진 중간 화합물은 의약품에 사용되는 다양한 화학제품의 제조에 사용될 뿐만 아니라 다양한 원료 의약품에도 존재합니다.

주요 인사이트

유형별로 보면 2023년 하이드롤라제는 리파아제, 아밀라아제, 프로테아제 등 다양한 생물학적 절차에 필수적인 효소로서 업계 매출의 40%를 차지했습니다.

용도별로는 2023년 식음료 카테고리가 25%의 매출 점유율을 차지했습니다.

원료별로는 미생물이 2023년 2억 달러의 매출을 기록했으며, 괄목할 만한 성장을 보일 것으로 전망됩니다.

지역별로 보면 2023년에는 북미 지역이 매출 기준 최대 지역으로 부상하며 큰 폭의 발전 궤도를 유지할 것으로 예상됩니다.

세계의 바이오 촉매 시장에 대해 분석했으며, 시장의 기본 구조와 최신 상황, 주요 촉진·억제요인, 세계 전체 및 지역별·주요 국가별 시장 규모 동향 전망(수량·금액 기준, 2017-2030년), 원료별·유형별·용도별 상세 동향, 현재 시장 경쟁 상황, 주요 기업 개요 등을 조사하여 전해드립니다.

목차

제1장 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 지표

제5장 업계 전망

  • 시장 역학
    • 동향
    • 성장 촉진요인
    • 성장 억제요인/과제
    • 성장 촉진요인/억제요인의 영향 분석
  • 신종 코로나바이러스 감염증(COVID-19)의 영향
  • Porter's Five Forces 분석

제6장 세계 시장

  • 개요
  • 시장 규모 : 원료별(2017-2030년)
  • 시장 매출 : 원료별(2017-2030년)
  • 시장 규모 : 종류별(2017-2030년)
  • 시장 매출 : 종류별(2017-2030년)
  • 시장 규모 : 용도별(2017-2030년)
  • 시장 매출 : 용도별(2017-2030년)
  • 시장 규모 : 지역별(2017-2030년)
  • 시장 매출 : 지역별(2017-2030년)

제7장 북미 시장

  • 개요
  • 시장 규모 : 원료별(2017-2030년)
  • 시장 매출 : 원료별(2017-2030년)
  • 시장 규모 : 종류별(2017-2030년)
  • 시장 매출 : 종류별(2017-2030년)
  • 시장 규모 : 용도별(2017-2030년)
  • 시장 매출 : 용도별(2017-2030년)
  • 시장 규모 : 지역별(2017-2030년)
  • 시장 매출 : 지역별(2017-2030년)

제8장 유럽 시장

제9장 아시아태평양 시장

제10장 라틴아메리카 시장

제11장 중동 및 아프리카 시장

제12장 미국 시장

  • 개요
  • 시장 규모 : 원료별(2017-2030년)
  • 시장 매출 : 원료별(2017-2030년)
  • 시장 규모 : 종류별(2017-2030년)
  • 시장 매출 : 종류별(2017-2030년)
  • 시장 규모 : 용도별(2017-2030년)
  • 시장 매출 : 용도별(2017-2030년)

제13장 캐나다 시장

제14장 독일 시장

제15장 프랑스 시장

제16장 영국 시장

제17장 이탈리아 시장

제18장 스페인 시장

제19장 일본 시장

제20장 중국 시장

제21장 인도 시장

제22장 호주 시장

제23장 한국 시장

제24장 브라질 시장

제25장 멕시코 시장

제26장 사우디아라비아 시장

제27장 남아프리카공화국 시장

제28장 아랍에미리트(UAE) 시장

제29장 경쟁 상황

  • 시장 진출 기업과 그 제공 제품/서비스 리스트
  • 주요 기업 경쟁 벤치마크
  • 주요 기업의 제품 벤치마크
  • 최근의 전략 전개 상황

제30장 기업 개요

  • Codexis Inc.
  • DuPont de Nemours Inc.
  • Koninklijke DSM N.V.
  • Novozymes
  • BASF SE
  • Amano Enzyme Inc.
  • Biocatalysts Limited
  • AB Enzymes GmbH
  • Lonza Group Ltd.
  • Chr. Hansen Holding A/S

제31장 부록

ksm 24.04.22

Market Overview

In 2023, the biocatalyst market was valued at USD 607.6 million and is projected to grow at a CAGR of 6.3% from 2024 to 2030, reaching USD 925.2 million by 2030.

Biocatalysts sourced from biological origins offer an eco-friendly substitute for synthetic catalysts, commonly derived from petroleum, across various industrial sectors. They play a significant role in producing both specialty and commodity chemicals.

The advancement of cost-effective genetic engineering techniques has significantly contributed to their increased manufacturing. These bio-enzymes enable precise reactions, leading to desired outcomes with minimal waste and fewer by-products, bolstering their appeal in industrial processes.

Biocatalysts are progressively becoming functional in biotransformation procedures, and therefore, they have become significant nearly in all industries, mainly chemicals, and pharmaceuticals. The growth of lucrative and ecological chemoenzymatic processes strongly relies on the extensive accessibility and pertinency of enzymes with high performance, irrespective of ecological conditions.

Biocatalysis guarantees that compound molecules are made with high accuracy while meeting severe quality standards. This adhesive their cruciality in the pharmacological sector, where accurate quality and concentrations are important.

The most prominent industrial applications of biocatalysis are stereospecific compounds (also called chiral compounds) used for pharmaceuticals aromas and fragrances. Chiral hydroxyl moieties medium compounds exist in various APIs as well as they are used in the production of various chemicals for use in pharmaceuticals.

Key Insights

In 2023, hydrolases held 40% of the industry revenue, essential in diverse biological procedures such as lipases, amidases, and proteases.

Hydrolases feature prominently in permitted medications for conditions such as Alzheimer's, diabetes, and communicable diseases.

These enzymes are also used in detergent formulations to eliminate blood and protein stains, guaranteeing clean clothes.

In 2023, the food & beverages category had a 25% revenue share among biocatalyst applications.

Biocatalysts are vital enzymes in food processing and additive production.

Sectors such as brewing, bakery, dairy, meat, beverages, and sugar use bio-enzymes widely.

Biocatalysis is favored because of growing ecological awareness and sustainability requirements, providing advanced effectiveness and safety.

Its sustainability stems from working under mild conditions and decreasing energy use, waste, and by-products.

Constant innovation permits biocatalysis to evolve and fulfill diverse market requirements efficiently.

In 2023, microorganisms contributed USD 0.2 billion to the industry, and the category is projected to showcase significant growth.

Enzymes from microbial sources are lucrative, scalable for wholesale production, and have high enzyme content.

Microbe-based enzymes are strong, quicken reactions efficiently, produce diverse compounds, and provide cost benefits.

In 2023, the North American region arose as the largest revenue contributor to the worldwide biocatalyst industry and is projected to uphold a substantial development trajectory.

This development is mainly propelled by the strong pharmaceutical and food sectors dominant in the region, which cater as major industry drivers.

The United States and Europe comprise the two leading superpowers of the world pharmaceutical industry, with America capturing 49.1% of the market and Europe controlling 23.4% of the global turnover of pharmaceuticals in 2021.

Statics from the European Federation of Pharmaceutical Industries and Associations (EFPIA) reveal the contribution of the United States and Europe was 64.4% and 16.2% respectively, newly drugs launched between 2016 and 2021.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by source
    • 1.4.2. Market size breakdown, by type
    • 1.4.3. Market size breakdown, by application
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Source (2017-2030)
  • 6.3. Market Revenue, by Source (2017-2030)
  • 6.4. Market Volume, by Type (2017-2030)
  • 6.5. Market Revenue, by Type (2017-2030)
  • 6.6. Market Volume, by Application (2017-2030)
  • 6.7. Market Revenue, by Application (2017-2030)
  • 6.8. Market Volume, by Region (2017-2030)
  • 6.9. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Source (2017-2030)
  • 7.3. Market Revenue, by Source (2017-2030)
  • 7.4. Market Volume, by Type (2017-2030)
  • 7.5. Market Revenue, by Type (2017-2030)
  • 7.6. Market Volume, by Application (2017-2030)
  • 7.7. Market Revenue, by Application (2017-2030)
  • 7.8. Market Volume, by Country (2017-2030)
  • 7.9. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Source (2017-2030)
  • 8.3. Market Revenue, by Source (2017-2030)
  • 8.4. Market Volume, by Type (2017-2030)
  • 8.5. Market Revenue, by Type (2017-2030)
  • 8.6. Market Volume, by Application (2017-2030)
  • 8.7. Market Revenue, by Application (2017-2030)
  • 8.8. Market Volume, by Country (2017-2030)
  • 8.9. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Source (2017-2030)
  • 9.3. Market Revenue, by Source (2017-2030)
  • 9.4. Market Volume, by Type (2017-2030)
  • 9.5. Market Revenue, by Type (2017-2030)
  • 9.6. Market Volume, by Application (2017-2030)
  • 9.7. Market Revenue, by Application (2017-2030)
  • 9.8. Market Volume, by Country (2017-2030)
  • 9.9. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Source (2017-2030)
  • 10.3. Market Revenue, by Source (2017-2030)
  • 10.4. Market Volume, by Type (2017-2030)
  • 10.5. Market Revenue, by Type (2017-2030)
  • 10.6. Market Volume, by Application (2017-2030)
  • 10.7. Market Revenue, by Application (2017-2030)
  • 10.8. Market Volume, by Country (2017-2030)
  • 10.9. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Source (2017-2030)
  • 11.3. Market Revenue, by Source (2017-2030)
  • 11.4. Market Volume, by Type (2017-2030)
  • 11.5. Market Revenue, by Type (2017-2030)
  • 11.6. Market Volume, by Application (2017-2030)
  • 11.7. Market Revenue, by Application (2017-2030)
  • 11.8. Market Volume, by Country (2017-2030)
  • 11.9. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Source (2017-2030)
  • 12.3. Market Revenue, by Source (2017-2030)
  • 12.4. Market Volume, by Type (2017-2030)
  • 12.5. Market Revenue, by Type (2017-2030)
  • 12.6. Market Volume, by Application (2017-2030)
  • 12.7. Market Revenue, by Application (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Source (2017-2030)
  • 13.3. Market Revenue, by Source (2017-2030)
  • 13.4. Market Volume, by Type (2017-2030)
  • 13.5. Market Revenue, by Type (2017-2030)
  • 13.6. Market Volume, by Application (2017-2030)
  • 13.7. Market Revenue, by Application (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Source (2017-2030)
  • 14.3. Market Revenue, by Source (2017-2030)
  • 14.4. Market Volume, by Type (2017-2030)
  • 14.5. Market Revenue, by Type (2017-2030)
  • 14.6. Market Volume, by Application (2017-2030)
  • 14.7. Market Revenue, by Application (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Source (2017-2030)
  • 15.3. Market Revenue, by Source (2017-2030)
  • 15.4. Market Volume, by Type (2017-2030)
  • 15.5. Market Revenue, by Type (2017-2030)
  • 15.6. Market Volume, by Application (2017-2030)
  • 15.7. Market Revenue, by Application (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Source (2017-2030)
  • 16.3. Market Revenue, by Source (2017-2030)
  • 16.4. Market Volume, by Type (2017-2030)
  • 16.5. Market Revenue, by Type (2017-2030)
  • 16.6. Market Volume, by Application (2017-2030)
  • 16.7. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Source (2017-2030)
  • 17.3. Market Revenue, by Source (2017-2030)
  • 17.4. Market Volume, by Type (2017-2030)
  • 17.5. Market Revenue, by Type (2017-2030)
  • 17.6. Market Volume, by Application (2017-2030)
  • 17.7. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Source (2017-2030)
  • 18.3. Market Revenue, by Source (2017-2030)
  • 18.4. Market Volume, by Type (2017-2030)
  • 18.5. Market Revenue, by Type (2017-2030)
  • 18.6. Market Volume, by Application (2017-2030)
  • 18.7. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Source (2017-2030)
  • 19.3. Market Revenue, by Source (2017-2030)
  • 19.4. Market Volume, by Type (2017-2030)
  • 19.5. Market Revenue, by Type (2017-2030)
  • 19.6. Market Volume, by Application (2017-2030)
  • 19.7. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Source (2017-2030)
  • 20.3. Market Revenue, by Source (2017-2030)
  • 20.4. Market Volume, by Type (2017-2030)
  • 20.5. Market Revenue, by Type (2017-2030)
  • 20.6. Market Volume, by Application (2017-2030)
  • 20.7. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Source (2017-2030)
  • 21.3. Market Revenue, by Source (2017-2030)
  • 21.4. Market Volume, by Type (2017-2030)
  • 21.5. Market Revenue, by Type (2017-2030)
  • 21.6. Market Volume, by Application (2017-2030)
  • 21.7. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Source (2017-2030)
  • 22.3. Market Revenue, by Source (2017-2030)
  • 22.4. Market Volume, by Type (2017-2030)
  • 22.5. Market Revenue, by Type (2017-2030)
  • 22.6. Market Volume, by Application (2017-2030)
  • 22.7. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Source (2017-2030)
  • 23.3. Market Revenue, by Source (2017-2030)
  • 23.4. Market Volume, by Type (2017-2030)
  • 23.5. Market Revenue, by Type (2017-2030)
  • 23.6. Market Volume, by Application (2017-2030)
  • 23.7. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Source (2017-2030)
  • 24.3. Market Revenue, by Source (2017-2030)
  • 24.4. Market Volume, by Type (2017-2030)
  • 24.5. Market Revenue, by Type (2017-2030)
  • 24.6. Market Volume, by Application (2017-2030)
  • 24.7. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Source (2017-2030)
  • 25.3. Market Revenue, by Source (2017-2030)
  • 25.4. Market Volume, by Type (2017-2030)
  • 25.5. Market Revenue, by Type (2017-2030)
  • 25.6. Market Volume, by Application (2017-2030)
  • 25.7. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Source (2017-2030)
  • 26.3. Market Revenue, by Source (2017-2030)
  • 26.4. Market Volume, by Type (2017-2030)
  • 26.5. Market Revenue, by Type (2017-2030)
  • 26.6. Market Volume, by Application (2017-2030)
  • 26.7. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Source (2017-2030)
  • 27.3. Market Revenue, by Source (2017-2030)
  • 27.4. Market Volume, by Type (2017-2030)
  • 27.5. Market Revenue, by Type (2017-2030)
  • 27.6. Market Volume, by Application (2017-2030)
  • 27.7. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Source (2017-2030)
  • 28.3. Market Revenue, by Source (2017-2030)
  • 28.4. Market Volume, by Type (2017-2030)
  • 28.5. Market Revenue, by Type (2017-2030)
  • 28.6. Market Volume, by Application (2017-2030)
  • 28.7. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Codexis Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. DuPont de Nemours Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Koninklijke DSM N.V.
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Novozymes
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. BASF SE
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Amano Enzyme Inc.
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Biocatalysts Limited
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. AB Enzymes GmbH
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Lonza Group Ltd.
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Chr. Hansen Holding A/S
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제